Ajay Major

1.1k total citations
60 papers, 382 citations indexed

About

Ajay Major is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Ajay Major has authored 60 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 20 papers in Hematology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Ajay Major's work include Multiple Myeloma Research and Treatments (16 papers), Lymphoma Diagnosis and Treatment (16 papers) and CAR-T cell therapy research (9 papers). Ajay Major is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Lymphoma Diagnosis and Treatment (16 papers) and CAR-T cell therapy research (9 papers). Ajay Major collaborates with scholars based in United States, Canada and United Kingdom. Ajay Major's co-authors include Manali Kamdar, Sonali M. Smith, Suzanne M. Cox, Samuel L. Volchenboum, Fay J. Hlubocky, Theodore Karrison, L. Mester, Hira Mian, Andrzej Jakubowiak and Tanya M. Wildes and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ajay Major

51 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ajay Major United States 12 158 129 101 90 45 60 382
C.A. Uyl-de Groot Netherlands 12 258 1.6× 118 0.9× 116 1.1× 54 0.6× 35 0.8× 28 553
Jane Jijun Liu United States 12 172 1.1× 67 0.5× 74 0.7× 59 0.7× 28 0.6× 23 405
Benjamin Barnes Germany 13 257 1.6× 86 0.7× 60 0.6× 52 0.6× 45 1.0× 29 530
Binay Kumar Shah United States 14 127 0.8× 160 1.2× 103 1.0× 52 0.6× 41 0.9× 45 484
İnci Alacacıoğlu Türkiye 12 157 1.0× 123 1.0× 36 0.4× 51 0.6× 43 1.0× 46 383
Rosemary Harrup Australia 13 71 0.4× 97 0.8× 73 0.7× 63 0.7× 37 0.8× 50 470
Giacomo Loseto Italy 11 158 1.0× 53 0.4× 87 0.9× 47 0.5× 11 0.2× 24 343
Meike Ressing Germany 11 93 0.6× 73 0.6× 53 0.5× 41 0.5× 43 1.0× 15 376
Don Vena United States 8 192 1.2× 67 0.5× 36 0.4× 96 1.1× 55 1.2× 13 502
Ardine Reedijk Netherlands 14 144 0.9× 98 0.8× 61 0.6× 64 0.7× 71 1.6× 23 500

Countries citing papers authored by Ajay Major

Since Specialization
Citations

This map shows the geographic impact of Ajay Major's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajay Major with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajay Major more than expected).

Fields of papers citing papers by Ajay Major

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajay Major. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajay Major. The network helps show where Ajay Major may publish in the future.

Co-authorship network of co-authors of Ajay Major

This figure shows the co-authorship network connecting the top 25 collaborators of Ajay Major. A scholar is included among the top collaborators of Ajay Major based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajay Major. Ajay Major is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sawalha, Yazeed, Shayna Sarosiek, Sudip Thapa, et al.. (2025). Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis. Blood Cancer Journal. 15(1). 65–65. 1 indexed citations
2.
3.
4.
Derman, Benjamin A., Jennifer H. Cooperrider, Tadeusz Kubicki, et al.. (2024). Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).. Journal of Clinical Oncology. 42(16_suppl). 106–106. 2 indexed citations
5.
Major, Ajay, Amylou C. Dueck, & Gita Thanarajasingam. (2024). SOHO State of the Art Updates and Next Questions | Measuring Patient-Reported Outcomes (PROs) and Treatment Tolerability in Patients With Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 25(3). 142–155. 2 indexed citations
6.
Derman, Benjamin A., Ajay Major, Jennifer H. Cooperrider, et al.. (2024). Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP). Blood Cancer Journal. 14(1). 10 indexed citations
7.
8.
Winters, Amanda, Mohd Minhajuddin, Brett M. Stevens, et al.. (2023). Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine. Haematologica. 109(6). 1766–1778. 5 indexed citations
9.
Major, Ajay, et al.. (2023). The Great Imitator: Aggressive Non-Hodgkin Lymphoma Presenting as a Cervical Mass. The American Journal of Medicine. 137(2). 107–109. 1 indexed citations
10.
Haverkos, Bradley M., Jasmine M. Zain, Manali Kamdar, et al.. (2023). Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial. Blood Advances. 8(3). 708–711. 2 indexed citations
11.
Derman, Benjamin A., Ajai Chari, Jeffrey A. Zonder, et al.. (2023). A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma. European Journal Of Haematology. 110(5). 564–570. 7 indexed citations
12.
Hess, Brian, Nasheed Hossain, Volkan Beylergil, et al.. (2023). SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA. Hematological Oncology. 41(S2). 839–840. 3 indexed citations
13.
Mian, Hira, Tanya M. Wildes, Ravi Vij, et al.. (2023). Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study. Blood Cancer Journal. 13(1). 26 indexed citations
14.
Major, Ajay, Pierluigi Porcu, & Bradley M. Haverkos. (2023). Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma. Cancers. 15(5). 1366–1366. 6 indexed citations
15.
16.
Major, Ajay, Benjamin W. Brewer, Sarah J. Schmiege, et al.. (2023). Longitudinal Patient-Reported Outcomes (PROs) in a Prospective Registry of CAR T-Cell Therapy Recipients. Blood. 142(Supplement 1). 2387–2387. 1 indexed citations
17.
Major, Ajay, et al.. (2022). Frontline polatuzumab vedotin for diffuse large B‐cell lymphoma: A survey of clinician impressions. SHILAP Revista de lepidopterología. 3(3). 930–935. 3 indexed citations
18.
Durani, Urshila, Ajay Major, Ana I. Velázquez, et al.. (2022). Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment. JCO Oncology Practice. 18(4). e586–e599. 8 indexed citations
19.
Major, Ajay, Suzanne M. Cox, & Samuel L. Volchenboum. (2020). Using big data in pediatric oncology: Current applications and future directions. Seminars in Oncology. 47(1). 56–64. 23 indexed citations
20.
Major, Ajay, et al.. (2019). Needle in a Haystack: A Missed Case of Wound Botulism. The American Journal of Medicine. 132(9). e677–e678. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.A. Uyl-de Groot Breakdown of academic impact, for papers by Jane Jijun Liu Breakdown of academic impact, for papers by Benjamin Barnes Breakdown of academic impact, for papers by Binay Kumar Shah Breakdown of academic impact, for papers by İnci Alacacıoğlu Breakdown of academic impact, for papers by Rosemary Harrup Breakdown of academic impact, for papers by Giacomo Loseto Breakdown of academic impact, for papers by Meike Ressing Breakdown of academic impact, for papers by Don Vena Breakdown of academic impact, for papers by Ardine Reedijk
Rankless by CCL
2026